Welcome to our dedicated page for Gabelli Health & Wellness SEC filings (Ticker: GRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) is a diversified, closed-end management investment company focused on healthcare and wellness sectors, with a primary objective of long-term capital growth. Although specific SEC documents are not listed here, a fund of this type typically files detailed reports that describe its portfolio, capital structure, and distribution practices.
On this page, GRX regulatory materials can be paired with AI-powered summaries that help explain the content and implications of lengthy filings. For a closed-end fund, key documents often include annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss investment objectives, sector exposures, risk factors, and financial statements. These filings also describe how the Fund’s distribution policy operates within the regulated investment company framework.
Investors interested in capital structure details may look to filings that discuss the issuance and redemption of cumulative preferred shares, including terms such as dividend rates, liquidation preferences, non-call periods, and mandatory redemption provisions. Filings can also provide more context on how proceeds from preferred offerings are used and how they relate to the Fund’s investment objectives.
For those tracking insider and governance information, SEC materials may include data on the Board of Trustees, management arrangements with Gabelli Funds, LLC, and other governance disclosures. Proxy materials can address topics such as advisory agreements and board oversight.
By combining real-time updates from EDGAR with AI-generated explanations, this page aims to make GRX’s regulatory history easier to review. Users can quickly identify the sections of each filing that relate to distributions, portfolio composition, preferred shares, and other structural features of The Gabelli Healthcare & WellnessRx Trust.
Saba Capital Management, L.P. reported two open-market purchases of Gabelli Healthcare & WellnessRx Trust (GRX) common stock on 09/11/2025 and 09/12/2025 at $9.43 per share. The first purchase was 6,147 shares, bringing indirect beneficial ownership to 2,043,303 shares; the second added 7,732 shares, increasing indirect ownership to 2,051,035. The filing lists the reporting person as a Director and a 10% owner and is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.
Saba Capital Management, L.P. and reporting person Boaz Weinstein reported an acquisition of Common Stock of Gabelli Healthcare & WellnessRx Trust (GRX). On 08/25/2025 they purchased 11,330 shares at $9.48 per share, and the filing shows 2,037,156 shares beneficially owned indirectly following the transaction. The Form 4 is signed and dated 08/26/2025 by Saba Capital and Boaz Weinstein.
The filing reports that Saba Capital Management, L.P. and Boaz Weinstein, both identified as a director and 10% owner, purchased 19,101 shares of Gabelli Healthcare & WellnessRx Trust (GRX) on 08/21/2025 at a price of $9.43 per share. After the transaction, the reporting persons are shown as beneficially owning 2,025,826 shares indirectly. The Form 4 reflects a routine insider purchase disclosed under Section 16.